Brief: Medexus Pharmaceuticals Inc Reports Q2 Revenue Rose 55 Percent To $27.7 Million

Medexus Pharmaceuticals

08/11/2022 23:32

Nov 8 (Reuters) - Medexus Pharmaceuticals Inc  MDP.TO :
    * MEDEXUS ANNOUNCES STRONGEST QUARTER IN COMPANY HISTORY
WITH
FISCAL Q2 2023 REVENUE OF US$27.7 MILLION, A 55% INCREASE OVER
FISCAL Q2 2022
    * MEDEXUS PHARMACEUTICALS INC Q2 REVENUE ROSE 55 PERCENT TO
$27.7
MILLION

Source text for Eikon:  ID:nGNX9GWR45 
Further company coverage:  MDP.TO 
 ((Reuters.Briefs@thomsonreuters.com;;))